Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients
Vicente Ruiz‐Carpio(Centro de Biología Molecular Severo Ochoa), Manuel López‐Cabrera(Consejo Superior de Investigaciones Científicas), Dorothea Piecha(Fresenius Medical Care (Germany)), María Luisa Pérez‐Lozano(Inserm), Patricia Albar-Vizcaíno(Hospital Universitario de La Princesa), M. Auxiliadora Bajo(Hospital Universitario La Paz), Pedro Botías(Universidad Complutense de Madrid), Guadalupe Tirma Gónzalez-Mateo(Centro de Biología Molecular Severo Ochoa), Jesús García‐Cantalejo(Universidad Complutense de Madrid), Adrián Acuña-Ruíz(Centro de Biología Molecular Severo Ochoa), Rafael Selgas(International Society for Peritoneal Dialysis), Sonja Steppan(Fresenius Medical Care (Germany)), José Antonio Sánchez-Tomero(Hospital Universitario de La Princesa), Jutta Passlick‐Deetjen(Fresenius Medical Care (Germany)), Pilar Sandoval(Consejo Superior de Investigaciones Científicas), Abelardo Aguilera(Hospital Universitario de La Princesa), Janine Büchel(Fresenius Medical Care (Germany))
Cited by 43
Related Papers
Carcinoma‐associated fibroblasts derive from mesothelial cells via mesothelial‐to‐mesenchymal transition in peritoneal metastasis
|The Journal of Pathology|2013|183
Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration
|Nephrology Dialysis Transplantation|2013|157
Mesothelial‐to‐mesenchymal transition in the pathogenesis of post‐surgical peritoneal adhesions
|The Journal of Pathology|2016|119
Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-κB/Snail1 pathway
|Disease Models & Mechanisms|2008|118
Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer
|The Journal of Pathology|2017|114